A new study published in BMC Pediatrics highlights the significant role parents play in shaping their children's media consumption, particularly when it comes to exposure to mature content such as ...

New research has identified novel rhinoconjunctivitis phenotypes in children with asthma which may not be allergy-driven, prompting the need for more research to better understand the pathology of ...

The primary and all key secondary endpoints were met compared to cream vehicle in the phase 3 DELTA TEEN trial. LEO Pharma A/S has reported positive phase 3 data for delgocitinib (Anzupgo) 20 mg /g ...

A loot into nutrition's role in acne care, highlighted by Colleen Sloan, PA-C, RDN. Acne is a common yet frustrating condition that affects nearly 85% of teenagers, often affecting their self-esteem ...

Panelists discuss the 2023 American Academy of Allergy, Asthma & Immunology/ American College of Allergy, Asthma & Immunology (AAAAI/ACAAI) Joint Task Force guidelines, highlighting treatment options ...

Navigating the ever-evolving landscape of pediatric care means staying ahead of clinical developments, regulatory shifts, and therapeutic breakthroughs—each with the potential to reshape how we ...

Panelists discuss the goals of treating atopic dermatitis, focusing on symptom control and quality of life, with treatment differing for children and adults, and emphasize using assessment tools such ...

The FDA is warning diabetes patients that information from CGMs, insulin pumps, and automated dosing systems could fail to be delivered if smartphone settings are not properly configured. In a new FDA ...

As a biosimilar to Actemra, tocilizumab-anoh in both IV and SC formulation is approved to treat rheumatoid arthritis, pJIA, sJIA, COVID-19, and giant cell arteritis. The FDA recently approved ...

The designations follow the FDA acceptance of IND application for ABO-101 to treat PH1, with a phase 1/2 study planned in the first half of 2025. The FDA has granted a pair of designations, both ...

Application submission is based on positive phase 3 data that demonstrated improvement in patients with type 2 and 3 SMA receiving current standard of care. Scholar Rock has submitted a biologics ...

Tina Tan, MD discusses the increased outbreaks of norovirus this year ...